Citation: | SUN Jing, FANG Yinquan, SONG Shu, ZHANG Luyong, LIAO Hong. Cannabinoid receptor agonist WIN55,212-2 inhibits glial scar formation after cerebral ischemia reperfusion injury[J]. Journal of China Pharmaceutical University, 2013, 44(2): 167-173. DOI: 10.11665/j.issn.1000-5048.20130213 |
[1] | QIU Jiwan, KONG Yong, CHEN Wei, XU Lei, CAO Chunjie, CHEN Tao, WU Yiliang. Generation and characterization of humanized monoclonal antibody against human IFNAR1[J]. Journal of China Pharmaceutical University, 2024, 55(3): 404-411. DOI: 10.11665/j.issn.1000-5048.2024031401 |
[2] | XU Qing, LYU Min, DENG Hongxiao, HU Chi, XIANG Ping, CHEN Hang. Advances in the application of machine learning in the identification and authentication of synthetic cannabinoids[J]. Journal of China Pharmaceutical University, 2024, 55(3): 316-325. DOI: 10.11665/j.issn.1000-5048.2023113003 |
[3] | LIU Shengfeng, ZHANG Lan, LIU Shucheng, HOU Chenzhi, XU Peng, DI Bin. Phase I metabolism of four amide synthetic cannabinoids in human liver microsomes[J]. Journal of China Pharmaceutical University, 2022, 53(5): 577-590. DOI: 10.11665/j.issn.1000-5048.20220508 |
[4] | WANG Xin, ZHAO Xiaomei, ZHANG Pingping, JI Xia, HU Guoqiang. Synthesis and antitumor activity of 1, 2-benzothiazines imidazolo [1, 2-b][1, 3, 4] triazazole derivatives[J]. Journal of China Pharmaceutical University, 2019, 50(5): 540-543. DOI: 10.11665/j.issn.1000-5048.20190505 |
[5] | LIU Yan, LI Chengye, CAI Xingguang, SUN Lidan, HUANG Wenlong. Synthesis and preliminary anti-diabetic activity evaluation of novel PEGylated GLP-1 receptor agonists[J]. Journal of China Pharmaceutical University, 2018, 49(5): 558-567. DOI: 10.11665/j.issn.1000-5048.20180507 |
[6] | HE Dongmei, YOU Qi, WU Jie. Application of microbial vaccines in type 1 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2018, 49(2): 158-164. DOI: 10.11665/j.issn.1000-5048.20180204 |
[7] | CHENG Yulan, MEN Jinxia, ZHOU Jinpei, ZHANG Huibin. Advances in indoleamine 2, 3-dioxygenase 1 inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(3): 361-370. DOI: 10.11665/j.issn.1000-5048.20170318 |
[8] | YIN Lei, WANG Ying, CHEN Song, GAO Xiangdong. Advances of glucagon-like peptide-1 receptor agonists in the treatment of nervous system diseases[J]. Journal of China Pharmaceutical University, 2014, 45(4): 383-391. DOI: 10.11665/j.issn.1000-5048.20140401 |
[9] | TANG Jianxing, WANG Weisheng, JI Hui, LIU Jinggen. Molecular mechanisms and function of intracellular GABAA receptor transportation[J]. Journal of China Pharmaceutical University, 2013, 44(2): 182-187. DOI: 10.11665/j.issn.1000-5048.20130216 |
[10] | A novel approach to pain therapy:Development of transient receptor potential vanilloid 1 antagonists[J]. Journal of China Pharmaceutical University, 2010, 41(1): 11-19. |